Literature DB >> 18343640

Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method.

Miguel Viveiros1, Ana Martins, Laura Paixão, Liliana Rodrigues, Marta Martins, Isabel Couto, Eva Fähnrich, Winfried V Kern, Leonard Amaral.   

Abstract

Demonstration of efflux of ethidium bromide (EtBr) has been made for over 30 bacterial species, usually by showing enhanced efflux in multidrug-resistant strains that was then abolished by inactivating efflux pumps. Here we present a relatively simple automated method that employs EtBr as an efflux pump substrate for the demonstration of intrinsic efflux activity in Escherichia coli K-12 AG100. The method uses the Rotor-Gene 3000 instrument for real-time fluorometric measurement of EtBr accumulation under conditions that limit energy (absence of glucose, low temperature) and of EtBr extrusion under optimum conditions. The method can be used for screening compound libraries for efflux inhibiting capacity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343640     DOI: 10.1016/j.ijantimicag.2007.12.015

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  38 in total

Review 1.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Changes in efflux pump activity of Clostridium beijerinckii throughout ABE fermentation.

Authors:  Barbora Branska; Maryna Vasylkivska; Hana Raschmanova; Katerina Jureckova; Karel Sedlar; Ivo Provaznik; Petra Patakova
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-06       Impact factor: 4.813

3.  Contribution of phenotypic heterogeneity to adaptive antibiotic resistance.

Authors:  María Antonia Sánchez-Romero; Josep Casadesús
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-18       Impact factor: 11.205

4.  Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.

Authors:  Maria Karczmarczyk; Marta Martins; Teresa Quinn; Nola Leonard; Séamus Fanning
Journal:  Appl Environ Microbiol       Date:  2011-08-19       Impact factor: 4.792

5.  Effects of Sublethal Thymol, Carvacrol, and trans-Cinnamaldehyde Adaptation on Virulence Properties of Escherichia coli O157:H7.

Authors:  Wenqian Yuan; Hyun-Gyun Yuk
Journal:  Appl Environ Microbiol       Date:  2019-07-01       Impact factor: 4.792

6.  Evolution combined with genomic study elucidates genetic bases of isobutanol tolerance in Escherichia coli.

Authors:  Jeremy J Minty; Ann A Lesnefsky; Fengming Lin; Yu Chen; Ted A Zaroff; Artur B Veloso; Bin Xie; Catie A McConnell; Rebecca J Ward; Donald R Schwartz; Jean-Marie Rouillard; Yuan Gao; Erdogan Gulari; Xiaoxia Nina Lin
Journal:  Microb Cell Fact       Date:  2011-03-25       Impact factor: 5.328

7.  The Role of Efflux Pumps and Environmental pH in Bacterial Multidrug Resistance.

Authors:  Márta Nové; Annamária Kincses; József Molnár; Leonard Amaral; Gabriella Spengler
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

8.  Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.

Authors:  Julia Mallegol; Prabhavathi Fernandes; Roberto G Melano; Cyril Guyard
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

9.  pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon.

Authors:  Ana Martins; Gabriella Spengler; Liliana Rodrigues; Miguel Viveiros; Jorge Ramos; Marta Martins; Isabel Couto; Séamus Fanning; Jean-Marie Pagès; Jean Michel Bolla; Joseph Molnar; Leonard Amaral
Journal:  PLoS One       Date:  2009-08-17       Impact factor: 3.240

10.  The TolC protein of Legionella pneumophila plays a major role in multi-drug resistance and the early steps of host invasion.

Authors:  Mourad Ferhat; Danièle Atlan; Anne Vianney; Jean-Claude Lazzaroni; Patricia Doublet; Christophe Gilbert
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.